Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
394 studies found for:    "Squamous cell carcinoma of the head and neck"
Show Display Options
Rank Status Study
21 Withdrawn Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Condition: Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
Interventions: Drug: sorafenib;   Drug: sorafenib and cisplatin
22 Completed Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Gefitinib;   Drug: methotrexate
23 Active, not recruiting Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: MEDI4736
24 Completed SUPREME-HN A Retrospective Cohort Study of PD-L1 in Recurrent and Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention:
25 Recruiting Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Valproic Acid;   Drug: Cisplatin;   Drug: Cetuximab
26 Completed Patritumab With Cetuximab and a Platinum Containing Therapy for Patients With Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Patritumab;   Drug: Cetuximab;   Drug: Cisplatin;   Drug: Carboplatin
27 Completed
Has Results
A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Interventions: Drug: Panitumumab;   Drug: Cisplatin;   Drug: 5FU
28 Completed
Has Results
A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: Cetuximab;   Drug: Cisplatin;   Drug: 5-Fluorouracil
29 Unknown  Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck
Condition: Squamous Cell Carcinoma of Head and Neck
Intervention: Drug: Pemetrexed
30 Active, not recruiting Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck
Conditions: Head and Neck Cancer;   Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cisplatin;   Drug: Docetaxel;   Drug: Erlotinib;   Other: Placebo;   Drug: Carboplatin
31 Recruiting Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: LEE011
32 Active, not recruiting Phase II Study of RAD001 Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Intervention: Drug: Everolimus 10mg daily
33 Completed Chromoendoscopy to Detect Early Synchronous Second Primary Esophageal Carcinoma
Condition: Squamous Cell Carcinomas of the Head and Neck
Intervention: Procedure: Esophagoscopy and chromoendoscopy
34 Completed Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Cabazitaxel 15mg/m2;   Drug: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
35 Active, not recruiting Study of DCA (Dichloroacetate) in Combination With Cisplatin and Definitive Radiation in Head and Neck Carcinoma
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: DCA (dichloroacetate);   Drug: Placebo
36 Unknown  Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Radiation: 3 Dimensional Radiation Therapy;   Radiation: Intensity Modulated Radiation Therapy
37 Terminated Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma Of The Head And Neck
Interventions: Drug: Cetuximab;   Drug: Dasatinib
38 Recruiting Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Pembrolizumab;   Other: Placebo
39 Completed Study of Unilateral Neck Irradiation in Patients With SCC of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Radiation: Radiation therapy;   Radiation: definitive external beam radiation in the ipsilateral neck
40 Active, not recruiting A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Biological: MEDI4736;   Biological: tremelimumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.